Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Daiichi Sankyo Company, Limited
  6. News
  7. All News
    4568   JP3475350009

DAIICHI SANKYO COMPANY, LIMITED

(4568)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about DAIICHI SANKYO COMPANY, LIMITED
03:39aSHIONOGI : Japan's Shionogi starts Phase II/III clinical trial for new COVID-19 vaccine
RE
10/18Nikkei 225 Edges Down 0.2% on Profit-Taking, Energy Outlook
MT
10/13PRESS RELEASE : Defence Therapeutics Inc.: DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO ..
DJ
10/11DAIICHI SANKYO : Corporate Governance Report
PU
10/05DAIICHI SANKYO : Astrazeneca - Enhertu granted Breakthrough Therapy Designation in US for ..
AQ
10/04Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca Receive Gra..
CI
10/04ASTRAZENECA : Daiichi Sankyo's Enhertu Gets US FDA Breakthrough Therapy Tag for Breast Can..
MT
10/04AstraZeneca Says FDA Granted Breakthrough-Therapy Designation for Cancer Treatment Enhe..
DJ
09/29DAIICHI SANKYO COMPANY, LIMITED : Ex-dividend day for interim dividend
FA
09/21Nikkei 225 Falls 2.2% on China Property Outlook
MT
09/20Japanese shares fall on Evergrande jitters; bargain-hunting limits losses
RE
09/20DAIICHI SANKYO : Enhertu reduced the risk of disease progression or death by 72% vs. trast..
AQ
09/20DAIICHI SANKYO : Enhertu demonstrated robust and durable tumour response of 54.9% in patie..
AQ
09/20ASTRAZENECA : Touts Positive Survival Data for Cancer Therapies Imfinzi, Enhertu
MT
09/20DAIICHI SANKYO : Enhertu demonstrated clinically meaningful and durable response in patien..
AQ
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Reduces Breast Cancer Death In Late-Stage Study
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Shows 55% Tumor Response Rate in Lung Cancer Patien..
MT
09/20ASTRAZENECA : Daiichi Sankyo's Enhertu Prolongs Survival in Mid-Stage Gastric Cancer Study
MT
09/18DAIICHI SANKYO : ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus T..
BU
09/18Daiichi Sankyo Company, Limited and AstraZeneca Announce Reduction of Risk of Disease P..
CI
09/18Daiichi Sankyo Company Demonstrated Robust and Durable Tumor Response of 54.9% in Patie..
CI
09/18Daiichi Sankyo Company, Limited and AstraZeneca announce ENHERTU® Demonstrated Clinical..
CI
09/17AstraZeneca Sees Positive Results for Enhertu Trial
DJ
09/17Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute, LLC Announce DS-73..
CI
09/16Japanese shares edge up as FOMO keeps rally alive
RE
09/16Daiichi Sankyo Company, Limited and AstraZeneca Announces That the First Patient Was Do..
CI
09/15China's biotech sector comes of age with big licensing deals, global ambitions
RE
09/07URAVAN MINERALS : Rises 20% as it Looks at Strategic Alternatives Because of Low Uranium P..
MT
08/30Daiichi Sankyo Company, Limited Announces Results from the Multinational, Randomized, C..
CI
08/20NIKKEI 225 : Declines 1% On Toyota, Pandemic Outlooks
MT
08/20Nikkei falls to 8-month low as Toyota drags peers, materials makers
RE
08/19Nikkei slides to 7-month low as Toyota drags peers, other cyclicals
RE
08/19Defence therapeutics selects the best 8 accumtm variants to optimize its adc therapeuti..
AQ
08/19Toyota drags Nikkei to 7-month low after output cut report
RE
08/18Japanese shares fall, struggle to shake off Delta variant fears
RE
08/18PRESS RELEASE : Defence therapeutics selects the best 8 accum(tm) variants to optimize its..
DJ
08/17NIKKEI 225 : Down 0.4% as Pandemic Undercuts Optimism
MT
08/12Interim Results for the Six Months Ended 30 June -2-
DJ
08/10LOGICBIO THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Highlights Recen..
AQ
08/10DAIICHI SANKYO : Enhertu significantly improved progression-free survival in DESTINY-Breas..
AQ
08/09ENHERTU® (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Progression-Free Surv..
CI
08/09ASTRAZENECA : Forxiga Nabs New EU Nod As Enhertu Logs Breast Cancer Win
MT
08/09ASTRAZENECA : Breast Cancer Drug Shown to Extend Lives Better Than Roche's Kadcyla in Phas..
MT
08/09DAIICHI SANKYO : ENHERTU® Significantly Improved Progression-Free Survival in DESTINY-Brea..
BU
07/30DAIICHI SANKYO : Consolidated Financial Results for the First Three Months of the Year End..
PU
07/30DAIICHI SANKYO : Top Management Presentation
PU
07/30DAIICHI SANKYO : Reference Data
PU
07/30Daiichi Sankyo Company, Limited Provides Dividend Guidance for the Year Ending March 31..
CI
07/30Daiichi Sankyo Company, Limited Forecasts Dividend for the Second Quarter of Fiscal Yea..
CI
07/30Daiichi Sankyo Company, Limited Provides Earnings Guidance for the Full Year Ending Mar..
CI
07/30Daiichi Sankyo Company, Limited Reports Consolidated Earnings Results for the First Qua..
CI
07/21Daiichi Sankyo Completes Issue of Shares in Stock Compensation Program
MT
07/08ASTRAZENECA : Daiichi Sankyo, AstraZeneca's Late-Stage Trial of Enhertu for Gastric Cancer..
MT
07/08ASTRAZENECA : Daiichi Sankyo Late-Stage Trial of Enhertu for Gastric Cancer Doses First Pa..
MT
07/08Daiichi Sankyo Company, Limited and AstraZeneca Announces DESTINY-Gastric04 Head-to-Hea..
CI
07/02Nikkei ends higher on Sony, Toyota boost; posts weekly drop on virus woes
RE
07/01TOKYO ELECTRIC POWER INCORPORATED : Olympics-Japan PM says no spectators possible as Samoa..
RE
06/23Daiichi Sankyo to Issue Common Stocks to Employees Under Share Compensation Plan
MT
06/22DAIICHI SANKYO : Corporate Governance Report
PU
06/15Japan's Daiichi Sankyo halts trials of existing drug for COVID-19 treatment
RE
06/14Japanese shares inch higher, Toshiba up after ouster of board directors
RE
06/13Japanese shares track Wall Street higher, gains capped as investors await Fed's stateme..
RE
06/11Daiichi Sankyo Company, Limited Announces New Data for valemetostat
CI
06/11Daiichi Sankyo Announces That Delytact® Oncolytic Virus G47 Approves in Japan for Treat..
CI
06/08Nikkei 225 Slips 0.2% on Inflation Outlook, Asian Market Softness
MT
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/04Daiichi Sankyo Company, Limited Announces Patritumab Deruxtecan Data at ASCO Demonstrat..
CI
06/04Daiichi Sankyo Company, Limited Announces New Data of Patritumab Deruxtecan (HER3-Dxd)
CI
06/02Japan shares rally as reopening hopes boosts travel, real estate firms
RE
06/01Japan shares rally as reopening hopes boosts travel, real estate firms
RE
05/31ETRION : Sells Niigata Solar Project for $57 Million, Expects Further Disposals in Coming ..
MT
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/27Japan to consider sharing COVID-19 vaccines amid calls to help Taiwan
RE
05/21Japan approves more COVID-19 vaccines, expands state of emergency
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on DAIICHI SANKYO COMPANY, LIMITED
10/29/21